Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 11(3): e1005097, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25807530

ABSTRACT

Here we demonstrate association of variants in the mitochondrial asparaginyl-tRNA synthetase NARS2 with human hearing loss and Leigh syndrome. A homozygous missense mutation ([c.637G>T; p.Val213Phe]) is the underlying cause of nonsyndromic hearing loss (DFNB94) and compound heterozygous mutations ([c.969T>A; p.Tyr323*] + [c.1142A>G; p.Asn381Ser]) result in mitochondrial respiratory chain deficiency and Leigh syndrome, which is a neurodegenerative disease characterized by symmetric, bilateral lesions in the basal ganglia, thalamus, and brain stem. The severity of the genetic lesions and their effects on NARS2 protein structure cosegregate with the phenotype. A hypothetical truncated NARS2 protein, secondary to the Leigh syndrome mutation p.Tyr323* is not detectable and p.Asn381Ser further decreases NARS2 protein levels in patient fibroblasts. p.Asn381Ser also disrupts dimerization of NARS2, while the hearing loss p.Val213Phe variant has no effect on NARS2 oligomerization. Additionally we demonstrate decreased steady-state levels of mt-tRNAAsn in fibroblasts from the Leigh syndrome patients. In these cells we show that a decrease in oxygen consumption rates (OCR) and electron transport chain (ETC) activity can be rescued by overexpression of wild type NARS2. However, overexpression of the hearing loss associated p.Val213Phe mutant protein in these fibroblasts cannot complement the OCR and ETC defects. Our findings establish lesions in NARS2 as a new cause for nonsyndromic hearing loss and Leigh syndrome.


Subject(s)
Aspartate-tRNA Ligase/genetics , Leigh Disease/genetics , RNA, Transfer, Amino Acyl/genetics , Adult , Amino Acid Sequence/genetics , Animals , Aspartate-tRNA Ligase/biosynthesis , Deafness/genetics , Deafness/pathology , Ear, Inner/metabolism , Ear, Inner/pathology , Female , Fibroblasts , Gene Expression/genetics , Genetic Predisposition to Disease , Humans , Leigh Disease/pathology , Male , Mice , Middle Aged , Mitochondria/genetics , Mitochondria/pathology , Mutation, Missense/genetics , Oxygen Consumption/genetics , Pedigree
2.
J Med Genet ; 51(3): 185-96, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24431331

ABSTRACT

INTRODUCTION: Lenz microphthalmia syndrome (LMS) is a genetically heterogeneous X-linked disorder characterised by microphthalmia/anophthalmia, skeletal abnormalities, genitourinary malformations, and anomalies of the digits, ears, and teeth. Intellectual disability and seizure disorders are seen in about 60% of affected males. To date, no gene has been identified for LMS in the microphthalmia syndrome 1 locus (MCOPS1). In this study, we aim to find the disease-causing gene for this condition. METHODS AND RESULTS: Using exome sequencing in a family with three affected brothers, we identified a mutation in the intron 7 splice donor site (c.471+2T→A) of the N-acetyltransferase NAA10 gene. NAA10 has been previously shown to be mutated in patients with Ogden syndrome, which is clinically distinct from LMS. Linkage studies for this family mapped the disease locus to Xq27-Xq28, which was consistent with the locus of NAA10. The mutation co-segregated with the phenotype and cDNA analysis showed aberrant transcripts. Patient fibroblasts lacked expression of full length NAA10 protein and displayed cell proliferation defects. Expression array studies showed significant dysregulation of genes associated with genetic forms of anophthalmia such as BMP4, STRA6, and downstream targets of BCOR and the canonical WNT pathway. In particular, STRA6 is a retinol binding protein receptor that mediates cellular uptake of retinol/vitamin A and plays a major role in regulating the retinoic acid signalling pathway. A retinol uptake assay showed that retinol uptake was decreased in patient cells. CONCLUSIONS: We conclude that the NAA10 mutation is the cause of LMS in this family, likely through the dysregulation of the retinoic acid signalling pathway.


Subject(s)
Anophthalmos/genetics , Microphthalmos/genetics , N-Terminal Acetyltransferase A/genetics , N-Terminal Acetyltransferase E/genetics , Signal Transduction/genetics , Tretinoin/metabolism , Anophthalmos/physiopathology , Cell Proliferation , Cells, Cultured , Female , Fibroblasts , Humans , Male , Microphthalmos/physiopathology , Mutation/genetics , Pedigree , Phenotype , RNA Splice Sites/genetics
3.
FASEB J ; 26(12): 4914-24, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22925728

ABSTRACT

Mitochondrial genome (mtDNA) mutation causes highly variable clinical features, and its pathogenesis is not fully understood. In this study, we analyzed the heteroplasmic mtDNA mutation C4936T (p.T156I) in ND2 of complex I and the homoplasmic mtDNA mutation A9181G (p.S219G) in ATPase 6 of complex V. Using cybrid technology, we found that in a high-glucose medium in which cultured cells mainly depend on anaerobic glycolysis for energy, the C4936T mutation inhibited cell growth by 50%. Oxygen consumption and reactive oxygen species production were also reduced by 60 and 75%, respectively. Because the subject also had conjunctiva carcinoma, we further tested whether the C4936T mutation was associated with tumor formation. In an anchorage-dependant growth test, we found that only cells with a high level of C4936T mutation formed colonies. In contrast, when the cells grew in a galactose medium in which cells were forced to generate ATP through oxidative phosphorylation, the C4936T mutation protected cells from apoptosis probably caused by the A9181G mutation. Our results suggest that the phenotype caused by mtDNA mutations may depend on the availability of the nutrients. This gene-environment interaction may contribute to the complexity of pathogenesis and clinical phenotypes caused by mtDNA mutation.


Subject(s)
Genome, Mitochondrial/genetics , Mitochondria/genetics , Mitochondria/metabolism , Point Mutation , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Adult , Apoptosis/genetics , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Proliferation/drug effects , Cells, Cultured , Electron Transport Complex I/genetics , Electron Transport Complex I/metabolism , Galactose/pharmacology , Humans , Hybrid Cells/metabolism , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Diseases/metabolism , Mitochondrial Diseases/pathology , Mitochondrial Proton-Translocating ATPases , Oxidative Phosphorylation/drug effects , Oxygen Consumption/genetics , Reactive Oxygen Species/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...